May 15 (Reuters)-
Daiken Medical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2023 Mar 31, 2022 Mar 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 9.14 8.54 9.60 4.65
(+7.0 pct) (+8.6 pct) (+5.1 pct) (+4.4 pct)
Operating 1.05 1.15 1.30 550 mln
(-8.4 pct) (+24.9 pct) (+23.3 pct) (-9.1 pct)
Recurring 1.05 1.15 1.30 550 mln
(-8.6 pct) (+20.4 pct) (+23.4 pct) (-9.1 pct)
Net 712 mln 831 mln 900 mln 380 mln
(-14.3 pct) (+23.1 pct) (+26.4 pct) (-11.5 pct)
EPS 24.79 yen 28.93 yen 31.33 yen 13.23 yen
Ann Div 20.00 yen 20.00 yen 20.00 yen
-Q2 Div 9.00 yen 9.00 yen 9.00 yen
-Q4 Div 11.00 yen 11.00 yen 11.00 yen
NOTE - Daiken Medical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7775.T